Cargando…
The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis
Background and Aim: The predominant species of the Enterococcus, Enterococcus faecalis (E. faecalis) and Enterococcus faecium (E. faecium) cause great variety of infections. Therefore, the expansion of antimicrobial resistance in the Enterococcus is one of the most important global concerns. This st...
Autores principales: | Dadashi, Masoud, Sharifian, Parastoo, Bostanshirin, Nazila, Hajikhani, Bahareh, Bostanghadiri, Narjess, Khosravi-Dehaghi, Nafiseh, van Belkum, Alex, Darban-Sarokhalil, Davood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460910/ https://www.ncbi.nlm.nih.gov/pubmed/34568377 http://dx.doi.org/10.3389/fmed.2021.720647 |
Ejemplares similares
-
The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis
por: Shariati, Aref, et al.
Publicado: (2020) -
Replacement of Enterococcus faecalis by Enterococcus faecium as the predominant enterococcus in UK bacteraemias
por: Horner, Carolyne, et al.
Publicado: (2021) -
Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report
por: Pincus, Nathan B., et al.
Publicado: (2022) -
Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia
por: Chacko, Kieran I., et al.
Publicado: (2018) -
1456. Resistance Mechanisms of Tigecycline in Enterococcus faecalis
por: Bai, Bing, et al.
Publicado: (2020)